Food & Drug Administration chief David Kessler's reviews on Capitol Hill have turned mixed. He wins wide praise in Congress for revitalizing the agency. But some lawmakers are worried by reports that Kessler has stirred up resentment within the FDA by replacing senior managers with his own people. "Management-wise, I think he's off to a bad start," says a worried Hill staffer.

Before it's here, it's on the Bloomberg Terminal.